Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05626426 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electrical Stimulation for the Treatment of Optic Neuropathies

Study acronym: rtACS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Eligibility criteria expanded, about 25 words
    • Secondary endpoints: details revised at 3 of 8 entries
    • Site details revised
  2. Enrollment target: 20 to 40v5 Show 4 more changesShow less
    • Primary completion date: Dec 2025 to Dec 2026
    • Study completion date: Dec 2025 to Dec 2027
    • Site contact updated
    • Collaborators shortened, about 6 words
  3. Primary and study completion dates: Dec 2024 to Dec 2025v4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2023 to Feb 27, 2023
    • Eligibility criteria shortened, about 11 words
    • Site details revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.
Trial Details
NCT Number NCT05626426
Lead Sponsor Stanford University
Conditions
(from sponsor)		 Glaucoma, Glaucoma, Open-Angle, Optic Nerve Diseases
Related terms Glaucoma, Glaucoma, Open-Angle, Optic Nerve Diseases
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov